Hybrid strategy of a bare metal stent combined with a drug-eluting stent versus exclusive drug-eluting stent implantation for multivessel percutaneous coronary intervention

EuroIntervention

Volumn 6, Issue 9, 2011, Pages 1085-1090

  Syed, Asmir I ^a   Ben Dor, Itsik ^a   Li, Yanlin ^a   Collins, Sara D ^a   Torguson, Rebecca ^a   Wakabayashi, Kohei ^a   Gonzalez, Manuel A ^a   Maluenda, Gabriel ^a   Delhaye, Cedric ^a   Belle, Loic ^a   Gaglia Jr , Michael A ^a   Xue, Zhenyi ^a   Kaneshige, Kimberly ^a   Bernardo, Nelson ^a   Kent, Kenneth M ^a   Suddath, William O ^a   Satler, Lowell F ^a   Pichard, Augusto D ^a   Lindsay, Joseph ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Bare metal stent; Drug eluting stent; Hybrid PCI; Multivessel PCI

Indexed keywords

AFRICAN AMERICAN; AGED; ARTICLE; BARE METAL STENT; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIVESSEL PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS CORONARY INTERVENTION; RISK FACTOR; STENT THROMBOSIS; TREATMENT OUTCOME; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; ETHNOLOGY; HEART INFARCTION; INSTRUMENTATION; MIDDLE AGED; MORTALITY; PATIENT SELECTION; PROPORTIONAL HAZARDS MODEL; PROSTHESIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICS; STENT; THROMBOSIS; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; UNITED STATES;

METAL;

AFRICAN AMERICANS; AGED; ANGIOPLASTY, BALLOON, CORONARY; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; DISTRICT OF COLUMBIA; DRUG-ELUTING STENTS; FEMALE; HOSPITAL MORTALITY; HUMANS; HYPERTENSION; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STENTS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 80051642191     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV6I9A189     Document Type: Article

References (23)

1. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-23. (Pubitemid 37186209)
2. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME; TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221-31. (Pubitemid 38067635)
3. Beohar N, Davidson CJ, Kip KE, Goodreau L, Vlachos HA, Meyers SN, Benzuly KH, Flaherty JD, Ricciardi MJ, Bennett CL, Williams DO. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA. 2007;297:1992-2000. (Pubitemid 46740351)
4. Win HK, Caldera AE, Maresh K, Lopez J, Rihal CS, Parikh MA, Granada JF, Marulkar S, Nassif D, Cohen DJ, Kleiman NS; EVENT Registry Investigators. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA. 2007;297:2001-9. (Pubitemid 46740352)
5. Food and Drug Administration (FDA) Update to FDA statement on coronary drug-eluting stents. htttp://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ PublicHealthNotifications/ucm062120.htm (last updated on 4/30/2009).
6. Farb A, Boam AB. Stent thrombosis redux - the FDA perspective. N Engl J Med. 2007;356:984-7. (Pubitemid 46376798)
7. Javaid A, Steinberg DH, Buch AN, Corso PJ, Boyce SW, Pinto Slottow TL, Roy PK, Hill P, Okabe T, Torguson R, Smith KA, Xue Z, Gevorkian N, Suddath WO, Kent KM, Satler LF, Pichard AD, Waksman R. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation. 2007;116:I200-6. (Pubitemid 47480791)
8. Mirabella F, Francaviglia B, Capodanno D, Di Salvo ME, Galassi AR, Ussia GP, Capranzano P, Tamburino C. Treatment of multilesion coronary artery disease with simultaneous drug-eluting and bare-metal stent implantation: clinical follow up and angiographic mid-term results. J Invasive Cardiol. 2009;21:145-50.
9. Krone RJ, Shaw RE, Klein LW, Block PC, Anderson HV, Weintraub WS, Brindis RG, McKay CR; ACC-National Cardiovascular Data Registry. Evaluation of the American College of Cardiology/American Heart Association and the Society for Coronary Angiography and Interventions lesion classification system in the current "stent era" of coronary interventions (from the ACC-National Cardiovascular Data Registry). Am J Cardiol. 2003;92:389-94. (Pubitemid 36959873)
10. Marroquin OC, Selzer F, Mulukutla SR, Williams DO, Vlachos HA, Wilensky RL, Tanguay JF, Holper EM, Abbott JD, Lee JS, Smith C, Anderson WD, Kelsey SF, Kip KE. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med. 2008;358:342-52. (Pubitemid 351159233)
11. Chieffo A, Morici N, Maisano F, Bonizzoni E, Cosgrave J, Montorfano M, Airoldi F, Carlino M, Michev I, Melzi G, Sangiorgi G, Alfieri O, Colombo A. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience Circulation. 2006;113:2542-7. (Pubitemid 43948033)
12. Dawkins KD, Grube E, Guagliumi G, Banning AP, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Popma JJ, Weissman NJ, Koglin J, Russell ME. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice Circulation. 2005;112:3306-13. (Pubitemid 43739376)
13. Dibra A, Kastrati A, Mehilli J, Pache J, Schühlen H, von Beckerath N, Ulm K, Wessely R, Dirschinger J, Schömig A; ISAR-DIABETES Study Investigators. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med. 2005;353:663-70. (Pubitemid 41175674)
14. Spaulding C, Henry P, Teiger E, Beatt K, Bramucci E, Carrié D, Slama MS, Merkely B, Erglis A, Margheri M, Varenne O, Cebrian A, Stoll HP, Snead DB, Bode C; TYPHOON Investigators. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med. 2006;355:1093-1104. (Pubitemid 44394916)
15. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Böhm M, Speck U. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med. 2006;355:2113-24 (Pubitemid 44749319)
16. Sabate M, Jimenez-Quevedo P, Angiolillo DJ, Gómez-Hospital JA, Alfonso F, Hernández-Antolín R, Goicolea J, Bañuelos C, Escaned J, Moreno R, Fernández C, Fernández-Avilés F, Macaya C; DIABETES Investigators. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation. 2005;112:2175-83. (Pubitemid 41475813)
17. Neumann FJ, Desmet W, Grube E, Brachmann J, Presbitero P, Rubartelli P, Mügge A, Di Pede F, Füllgraf D, Aengevaeren W, Spedicato L, Popma JJ. Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation 2005;111:2107-11. (Pubitemid 40577906)
18. Suttorp MJ, Laarman GJ, Rahel BM, Kelder JC, Bosschaert MA, Kiemeneij F, Ten Berg JM, Bal ET, Rensing BJ, Eefting FD, Mast EG. Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions. Circulation. 2006;114:921-8. (Pubitemid 44337135)
19. Varani E, Saia F, Balducelli M, Guastaroba P, Marrozzini C, Tarantino F, Passerini F, Sangiorgio P, Percoco G, Grilli R, Marzocchi A, Maresta A. Percutaneous treatment of multivessel coronary disease in the drug eluting stent era: comparison of bare-metal stents, drug-eluting stents and a mixed approach in a large multicentre registry. EuroIntervention. 2007;2:474-80.
20. http://www.cordis.com/active/crdus/en-US/html/cordis/downloads/DES-guide. pdf
21. http://www.americanheart.org/presenter.jhtml?identifier=4439
22. Filion KB, Roy AM, Baboushkin T, Rinfret S, Eisenberg MJ. Cost-effectiveness of drug eluting stents including economic impact of late stent thrombosis. Am J Cardiol. 2009;103:338-44.
23. King SB, Smith SC, Hirshfeld JW, Jacobs AK, Morrison DA, Williams DO. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol. 2008;51:172-209.